PUBLISHER: Allied Market Research | PRODUCT CODE: 1140110
PUBLISHER: Allied Market Research | PRODUCT CODE: 1140110
The global biomedical warming and thawing devices market was valued at $159.3 million in 2021, and is projected to reach $376.7 million by 2031, registering a CAGR of 9.1% from 2022 to 2031. Biomedical warming and thawing devices are typically used to defrost samples of blood, tissues, cells, and other biologics. Cryopreservation is known as a method of successfully and safely preserving cells and tissues at a lower temperature, often below freezing point. It is therefore necessary to defrost these biological products before use, and in this case, biomedical warming and thawing equipment play a crucial role by assisting in the warming and defrosting of cryopreserved products.
They also reduce the possibility that cryo-preservative chemicals would harm these objects, as extended exposure to such chemicals might impair the preserved materials' living cells and other components. For stored cells to remain effective and viable for use in medical procedures, the use of biomedical warming and thawing devices is essential.
The biomedical warming and thawing devices market is anticipated to develop as more cryopreservation techniques are used to preserve cells and tissues. Increased demand for automated biomedical warming and thawing equipment is also helping the market grow. Growing need for pharmaceutical research is also anticipated to boost the rate of adoption for biomedical warming and thawing devices, thus, driving the market growth during the forecast period. The biomedical warming and thawing devices market is driven by rise in the number of blood banks and blood infusion centers, numerous advantages offered by automatic biomedical warming and thawing devices, and increase in the number of road accidents and trauma cases leading to blood transfusions. Biomedical warming and thawing devices are used in blood bank for preservation of plasma, stem cells, whole blood & RBCs (red blood cells), and platelets. Thus, increase in the number of blood banks and blood infusion centers is anticipated to drive the market growth.
Moreover, surge in demand for blood donation causes increase in the usage of warming and thawing devices for preservation of blood. Thus, this factor is anticipated to fuel the growth of the market. For instance, according to the World Health Organization, in 2020, globally, 118.5 million blood donations are collected each year. Around 85 million units of blood are given to patients each year. As per the same source, up to 54% of blood transfusions were given to children under 5 years of age in low-income countries; whereas, the most frequently transfused patient group was over 60 years of age, accounting for up to 75% of all transfusions in high-income countries.
Biomedical warming and thawing devices have a wide range of applications in pharmaceutical and biotechnology field for various research and studies, tissue culturing, and animal & plant engineering. Moreover, surge in number of patients for admission in medical emergency departments and rise in the number of road traffic accidents resulting in need of blood transfusion. Thus, these factors increase the demand for biomedical warming and thawing devices, which fuels the market growth. In addition, technological advancement in the healthcare sector and rise in R&D activities drive the growth of the biomedical warming and thawing devices market. On the other hand, strict regulation related to thawed biomedical products and samples and use of cryopreserved are anticipated to hinder the growth of the market. In addition, technical concerns, such as low survival biomaterial sample loss of cellular characteristics, altered gene expression, epigenic changes, and shift in protein composition are expected to limit the growth of the biomedical warming and thawing devices market.
The biomedical warming and thawing devices market is segmented on the basis of product, sample, end user, and region. On the basis of product, the market is segmented into manual and automatic. On the basis of sample market is segmented into blood products, stem cells, embryo, ovum, and others. Blood products is further bifurcated into plasma, & RBCs. By end user, the market is bifurcated into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and blood banks & stem cell banks. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biomedical warming and thawing devices market include, Barkey GmbH & co. kg, Boekel Scientific, Cardinal Health, Conroy Medical AB., Cytiva, CytoTherm, Eppendorf, Farrar Scientific, Fisher Scientific PTE LTD (Thermo Fisher Scientific), FreMon Scientific, Inc., GE, Helmer Scientific, KW Apparecchi Scientifici, Sarstedt AG & Co. KG, Sartorius AG, and Thaw World Medical Ltd.
Key Benefits For Stakeholders
Key Market Segments
By Product
By Sample Type
By End User
By Region